A Zantac lawsuit refers to a financial compensation claim made by those who suffered carcinoma after consuming the heartburn medication. The compensation claim is made on the ground that the manufacturer failed to warn the patients and their doctors that this heartburn medicine contains a carcinogen (NDMA). The same carcinogen is supposed to have caused cancer in those who consumed Losartan and Valsartan, blood pressure medicines.

If any of your loved one has reasons to believe that consumption of Zantac caused cancer, the victim is entitled to sue the drug manufacturer and claim compensation from the same. Not all Zantac Ranitidine Lawsuits are integral to a class action. There are plenty of individual lawsuits filed by the victims against the manufacturer.

Anyone, who has developed any of the followings, after consuming Zantac, is entitled to file a compensation claim:

  • Stomach Cancer
  • Bladder Cancer
  • Pancreatic Cancer
  • Liver cancer
  • Prostate Cancer
  • Esophageal Cancer
  • Colon Cancer
  • Rectal Cancer
  • Multiple Myeloma
  • Non-Hodgkins Lymphoma
  • Leukemia

Grounds for Zantac Lawsuits

  • Defective design of a drug
  • The manufacturer’s failure to warn patients and physicians about its risks

Defective Design

The drug manufacturers are legally responsible if the defective design of the drug posed a predictable risk. NDMA is a natural cancer-causing by-product of the ingredients used in making of ranitidine.

As a matter of fact, the name of the company that manufactured the drug is not a concern. This is because, Zantac creates NDMA by automatically reacting with the body’s chemistry. Therefore, the medication has potentials to cause cancer.

The original Zantac formula is the common proof of the medicine’s design defect. The plaintiffs’ lawyers will use expert witnesses to establish the allegations of design defects.

Failure to Warn/Improper Labelling

Zantac has, like other medications, a warning label. Unfortunately, the label makes no mention of its cancer-causing potentials. Had doctors been aware of the potential risks, they may not have prescribed the medicine. The same goes true for the patients. Had they known about the risks, they may not have taken it.

Zantac packaging is the best evidence of the manufacturer’s failure to warn the physicians and potential consumers. No mention about the presence of NDMA-related information on the packaging suggests that patients were not fully aware of its potential dangers.

The plaintiffs need to prove that they actually took the medicine. Regular usage for a long period of time strengthens their point. The following evidences will help their case:

  • Receipts
  • Pharmacy Records
  • Packaging/Pill Bottles
  • Medical Records Showing that the Plaintiff Got Cancer after Taking the Medicine

Individual Lawsuit or Class Action

Every individual Zantac lawsuit will be jointed into a ‘Multi-District Litigation’. The MDL judge will allow a few cases to proceed to trials.

Fundamentally, MDLs are unlike class actions. All cases in class actions eventually get combined but every case in MDLs remains separate.

If you intend to file a lawsuit against the Zantac manufacturer for developing cancer after consuming the medication, talk to an experienced lawyer for compensation claim.